+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Menopause Market by Product Type, Stage of Menopause, Route of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Menopause Market by Product Type, Stage of Menopause, Route of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Menopause Market by Product Type, Stage of Menopause, Route of Administration, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454968
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Menopause Market has witnessed significant growth, expanding from USD 19.97 billion in 2024 to USD 21.39 billion in 2025, with projections indicating a rise to USD 30.52 billion by 2030 at a CAGR of 7.32%. This growth trajectory highlights critical opportunities for market participants seeking to capitalize on evolving consumer needs and technological advancements.

Navigating the Menopause Market: Executive Overview

The menopause market is poised at the crossroads of significant demographic changes, cutting-edge technological innovations, and shifting patient expectations. As the global population ages, the number of women entering menopause increases, generating heightened demand for symptom management ranging from hot flashes to complex health concerns. At the same time, advancements in hormone science and non-hormonal interventions are reshaping treatment paradigms and creating avenues for new developments.

Industry players must develop a sophisticated understanding of patient experiences, regulatory requirements, and emerging treatments to thrive in this dynamic environment. By synthesizing data from epidemiological studies, clinical advancements, and changing payer policies, decision-makers are equipped with essential insights to navigate this complex market landscape effectively.

Emerging Forces Reshaping Menopause Care

Transformative shifts in menopause care are being driven by scientific innovation, empowered patients, and progressive market strategies. Advances in hormone replacement technology have resulted in safer and more tailored delivery systems, enhancing acceptance among healthcare providers and patients. The rise of non-hormonal therapies, such as selective serotonin reuptake inhibitors and botanical solutions, offers alternative symptom management routes that foster a personalized care ecosystem.

Digital health platforms and telemedicine are revolutionizing patient interactions, providing tools for remote symptom monitoring, virtual consultations, and supportive community networks, thus improving adherence and outcomes. Integrating real-world evidence into clinical decisions accelerates product lifecycle strategies, enabling rapid adjustments to meet evolving guidelines and preferences. Companies that leverage these drivers can achieve a competitive edge in a swiftly changing market.

Tariff Dynamics and Their Market Impact in 2025

In 2025, new U.S. tariffs introduced complex cost structures affecting the menopause treatment sector. Tariffs on imported raw materials essential for hormone therapy manufacture have increased costs for both domestic and international producers, prompting supply chain entities to explore local partnerships and alter sourcing strategies. Tariff variations also impact competitive dynamics within treatment delivery formats.

Manufacturers with local production capabilities have navigated tariffs to offer cost-effective solutions in price-sensitive markets, reshaping payer negotiations as insurers balance acquisition costs with enhanced adherence linked to advanced delivery systems. The tariff landscape necessitates robust scenario planning and agile procurement practices to adapt to shifting regulatory conditions.

Key Takeaways from This Report

  • Advancements in menopause care are driven by technology and patient empowerment, leading to a diversified treatment ecosystem.
  • Digital health solutions enhance patient engagement and treatment adherence, providing a competitive advantage to proactive companies.
  • Tariff dynamics in 2025 require strategic planning to mitigate financial impacts and leverage local manufacturing advantages.
  • Companies poised for growth actively engage in R&D, strategic partnerships, and localized strategies to meet regional market needs.

Unveiling Consumer and Product Segmentation Trends

Market segmentation reveals complex relationships between product types, menopausal stages, administration methods, and distribution pathways. Hormone replacement remains a foundation in care, while non-hormonal treatments are increasingly important, particularly antidepressants and natural supplements. Life-stage targeting refines strategies, with perimenopausal women preferring quick interventions and postmenopausal women focusing on long-term health.

Channels of distribution shift with consumer behaviors: hospital pharmacies serve complex cases, while retail and online pharmacies offer convenience and discretion. This segmented approach guides product alignment, marketing, and support programs to meet the needs of diverse consumer groups.

Regional Growth Patterns and Market Dynamics

Regional dynamics exhibit distinct growth patterns tied to socioeconomic and healthcare variations. In the Americas, robust reimbursement systems aid the uptake of emerging therapies, while regions like Latin America emphasize cost-effective alternatives. Europe, the Middle East, and Africa's varied regulatory environments present both challenges and opportunities, influenced by safety standards and telehealth receptivity.

Asian markets demonstrate strong demand due to demographic growth and healthcare investments, with rising middle-class buying power boosting non-hormonal and digital health solutions. Tailoring strategies to regional specifics supports competitive positioning and market expansion.

R&D-Focused Leadership

Industry leadership is maintained by entities that balance strong research pipelines with strategic market execution. Comprehensive patient education and targeted clinical trials strengthen portfolios. Collaborations between biotech companies and digital health startups enhance delivery and adherence, reflecting a shift toward integrated care models.

Leaders are those who effectively align innovation with operational efficiency, investing wisely in R&D, partnerships, and digital applications, ensuring relevance in a market defined by innovation and patient-centricity.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Menopause Market, by Product Type
8.1. Introduction
8.2. Hormone Replacement Therapy (HRT)
8.2.1. Combined Estrogen-Progesterone Therapy
8.2.2. Estrogen Therapy
8.2.3. Progesterone Therapy
8.3. Non-Hormonal Treatments
8.3.1. Antidepressants
8.3.1.1. Citalopram
8.3.1.2. Escitalopram
8.3.1.3. Fluoxetine
8.3.2. Botanical Supplements
8.3.3. Gabapentin
8.3.4. Pregabalin
9. Menopause Market, by Stage of Menopause
9.1. Introduction
9.2. Menopause
9.3. Perimenopause
9.4. Postmenopause
10. Menopause Market, by Route of Administration
10.1. Introduction
10.2. Enteral
10.3. Parenteral
10.4. Topical
11. Menopause Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.3.1. Company Websites
11.3.2. eCommerce Platforms
11.4. Retail Pharmacies
12. Americas Menopause Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Menopause Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Menopause Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. Abbvie Inc.
15.3.3. Amgen Inc.
15.3.4. Apotex Inc.
15.3.5. Astellas Pharma Inc.
15.3.6. AstraZeneca PLC
15.3.7. Bayer AG
15.3.8. Cipla Ltd.
15.3.9. Eli Lilly and Company
15.3.10. Ferring International Center S.A.
15.3.11. Fervent Pharmaceuticals, LLC
15.3.12. Gedeon Richter PLC
15.3.13. GlaxoSmithKline PLC
15.3.14. Glenmark Pharmaceuticals Ltd.
15.3.15. Ipsen Group
15.3.16. Merck & Co.Inc.
15.3.17. Mithra Pharmaceuticals S.A.
15.3.18. Novartis AG
15.3.19. Novo Nordisk A/S
15.3.20. Organon & Co
15.3.21. Pfizer Inc.
15.3.22. Sun Pharmaceutical Industries Ltd.
15.3.23. Teva Pharmaceutical Industries Ltd.
15.3.24. TherapeuticsMD Inc.
15.3.25. Viatris Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. MENOPAUSE MARKET MULTI-CURRENCY
FIGURE 2. MENOPAUSE MARKET MULTI-LANGUAGE
FIGURE 3. MENOPAUSE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MENOPAUSE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINED ESTROGEN-PROGESTERONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MENOPAUSE MARKET SIZE, BY ESTROGEN THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MENOPAUSE MARKET SIZE, BY PROGESTERONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MENOPAUSE MARKET SIZE, BY CITALOPRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MENOPAUSE MARKET SIZE, BY ESCITALOPRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MENOPAUSE MARKET SIZE, BY FLUOXETINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MENOPAUSE MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MENOPAUSE MARKET SIZE, BY GABAPENTIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MENOPAUSE MARKET SIZE, BY PREGABALIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MENOPAUSE MARKET SIZE, BY MENOPAUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MENOPAUSE MARKET SIZE, BY PERIMENOPAUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MENOPAUSE MARKET SIZE, BY POSTMENOPAUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MENOPAUSE MARKET SIZE, BY ENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MENOPAUSE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MENOPAUSE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MENOPAUSE MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MENOPAUSE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 39. AMERICAS MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. CANADA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 57. CANADA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 58. CANADA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 59. CANADA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 60. CANADA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. CANADA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 63. MEXICO MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 65. MEXICO MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 67. MEXICO MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. MEXICO MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 73. BRAZIL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 104. GERMANY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. GERMANY MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 106. GERMANY MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 107. GERMANY MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 108. GERMANY MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 109. GERMANY MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. GERMANY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. GERMANY MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 112. FRANCE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. FRANCE MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 114. FRANCE MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 115. FRANCE MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 116. FRANCE MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. FRANCE MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 122. RUSSIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 128. ITALY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 130. ITALY MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 131. ITALY MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 132. ITALY MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 133. ITALY MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. ITALY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. ITALY MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 136. SPAIN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. SPAIN MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 138. SPAIN MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 139. SPAIN MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 140. SPAIN MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 141. SPAIN MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. SPAIN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. SPAIN MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 168. DENMARK MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. DENMARK MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 170. DENMARK MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 171. DENMARK MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 172. DENMARK MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 173. DENMARK MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. DENMARK MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. DENMARK MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 184. QATAR MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. QATAR MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 186. QATAR MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 187. QATAR MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 188. QATAR MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 189. QATAR MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. QATAR MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 192. FINLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 194. FINLAND MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 195. FINLAND MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 196. FINLAND MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. FINLAND MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 202. SWEDEN MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 210. NIGERIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 216. EGYPT MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. EGYPT MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 218. EGYPT MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 219. EGYPT MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 220. EGYPT MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 221. EGYPT MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 222. EGYPT MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. EGYPT MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 224. TURKEY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 226. TURKEY MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 228. TURKEY MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. TURKEY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. TURKEY MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 234. ISRAEL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 240. NORWAY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. NORWAY MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 242. NORWAY MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 243. NORWAY MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 244. NORWAY MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. NORWAY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. NORWAY MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 248. POLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. POLAND MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 250. POLAND MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 251. POLAND MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 252. POLAND MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 253. POLAND MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. POLAND MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 273. CHINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. CHINA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 275. CHINA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 276. CHINA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 277. CHINA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 278. CHINA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. CHINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. CHINA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 281. INDIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. INDIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 283. INDIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 284. INDIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 285. INDIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 286. INDIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. INDIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. INDIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 289. JAPAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. JAPAN MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 291. JAPAN MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 292. JAPAN MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 293. JAPAN MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 294. JAPAN MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 295. JAPAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. JAPAN MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 315. INDONESIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 321. THAILAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 322. THAILAND MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 323. THAILAND MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 324. THAILAND MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 325. THAILAND MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 326. THAILAND MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 327. THAILAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. THAILAND MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 344. MALAYSIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 351. SINGAPORE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 352. SINGAPORE MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 353. VIETNAM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 354. VIETNAM MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 355. VIETNAM MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 356. VIETNAM MEN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Menopause market report include:
  • Abbott Laboratories
  • Abbvie Inc.
  • Amgen Inc.
  • Apotex Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Cipla Ltd.
  • Eli Lilly and Company
  • Ferring International Center S.A.
  • Fervent Pharmaceuticals, LLC
  • Gedeon Richter PLC
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Ipsen Group
  • Merck & Co.Inc.
  • Mithra Pharmaceuticals S.A.
  • Novartis AG
  • Novo Nordisk A/S
  • Organon & Co
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD Inc.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 21.39 Billion
Forecasted Market Value ( USD ) by 2030 $ 30.52 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Menopause Market Report 2025 - Product Image

Menopause Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Menopause - Global Strategic Business Report - Product Image

Menopause - Global Strategic Business Report

  • Report
  • 181 Pages
  • Global
From
Vasomotor Symptoms Of Menopause - Pipeline Insight, 2025 - Product Image

Vasomotor Symptoms Of Menopause - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Menopause Associated Vasomotor Symptoms - Pipeline Insight, 2025 - Product Image

Menopause Associated Vasomotor Symptoms - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Menopause), By Drug Class (Hormonal Therapies, Pain And Symptom Management), By Age (50 Years And Above), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Menopause), By Drug Class (Hormonal Therapies, Pain And Symptom Management), By Age (50 Years And Above), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From

About the Menopause Market

The Menopause market is a subset of the Women's Health industry, focusing on the physical and emotional changes experienced by women during the transition from reproductive to non-reproductive years. It includes products and services that help women manage the symptoms of menopause, such as hot flashes, night sweats, mood swings, and vaginal dryness. It also includes treatments for conditions associated with menopause, such as osteoporosis, heart disease, and urinary incontinence. The Menopause market is a growing industry, with an increasing number of products and services available to women. Companies in the market include pharmaceutical companies, health care providers, and wellness companies. Examples include Hormone Health Network, Menopause Solutions, and Menopause Support. Additionally, there are a number of online resources and support groups available to women going through menopause. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.